Streetbeat News

Products Services

AQST

Aquestive Therapeutics, Inc. (NASDAQ:AQST) will present positive topline data from pharmacokinetic and pharmacodynamic studies of Anaphylm, an epinephrine sublingual film for the emergency treatment of severe allergic reactions, at the Aspen Allergy Conference. The company believes Anaphylm has the potential to provide a highly differentiated product to patients.

Portfolio Pulse from Happy Mohamed

July 25, 2023 | 12:17 pm

MRK

PDSB

PDS Biotechnology's abstract detailing immune response data from the VERSATILE-002 Phase 2 trial of PDS0101 combined with Merck's Keytruda, in head & neck cancer has been accepted for presentation at the ESMO Congress 2023.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2023 | 12:16 pm

DOGEUSD

Speculations have arisen about Elon Musk's potential use of Dogecoin (CRYPTO: DOGE) for global payments on Twitter's rebranded platform, 'X'. Macro Guru and former Goldman Sachs executive Raoul Pal suggested that Musk might use Dogecoin as a medium for global payments to content creators on the platform. This speculation was fueled by changes in Musk's Twitter bio, which now includes an 'X' and a 'D', interpreted as references to Twitter's rebranding and Dogecoin respectively.

Portfolio Pulse from Mehab Qureshi

July 25, 2023 | 12:12 pm

DT

Dynatrace has announced that it is expanding its Davis AI engine to create a hypermodal artificial intelligence system. This new system will converge predictive, causal, and generative AI.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2023 | 12:12 pm

ECOR

ElectroCore has announced the publication of a peer-reviewed manuscript that shows improved attention and memory in patients with Posttraumatic Stress Disorder (PTSD) using GammaCore, a non-invasive vagus nerve stimulation device.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2023 | 12:09 pm

W

Wayfair has launched Decorify, a virtual room styler powered by generative AI. This pilot solution aims to help customers design and shop for their homes more easily.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2023 | 12:08 pm

G

MSFT

Genpact has partnered with Microsoft to equip its workforce with generative AI tools. The company will leverage Microsoft Azure OpenAI Service technology to enhance the speed-to-market of solutions that help companies use data and AI's power to drive actionable business insights.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2023 | 12:08 pm

DOCU

DocuSign has launched a new AI-powered ID verification solution that uses live video selfies to make the process more convenient and prevent identity spoofing and deep-fakes.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2023 | 12:06 pm

MLTX

Moonlake Immunotherapeutics has completed the randomization of the target 200 patients in its global Phase 2 ARGO trial evaluating Nanobody Sonelokimab in active psoriatic arthritis, several weeks ahead of schedule.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2023 | 12:04 pm

BFRG

BullFrog AI has announced a US patent for novel prodrugs of mebendazole, which are used in treating cancer. This news has led to an increase in the company's share price.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2023 | 11:59 am